Last updated: May 7, 2024
Sponsor: University of Haifa
Overall Status: Active - Recruiting
Phase
3
Condition
Depression
Depression (Adult And Geriatric)
Mood Disorders
Treatment
Supportive-expressive treatment
Emotions-Focused treatment
Clinical Study ID
NCT04576182
ISF 395/19
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Meeting major depressive disorder diagnostic criteria using the structured clinicalinterviews for Diagnostic and Statistical Manual of Mental Disorders-5 and scoringmore than 14 on the 17-item Hamilton rating scale for depression at two evaluations (one week apart) (Hamilton, 1967).
- If on medication, patients' dosage must be stable for at least three months prior toentering the study, and they must be willing to maintain stable dosage for theduration of treatment
- Age between 18 and 65
- Hebrew language fluency
- Provision of written informed consent.
Exclusion
Exclusion Criteria:
- Current risk of suicide or self-harm
- current substance abuse disorders
- current or past schizophrenia or psychosis, bipolar disorder, or severe eatingdisorder requiring medical monitoring
- history of organic mental disease
- currently in psychotherapy
Study Design
Total Participants: 124
Treatment Group(s): 2
Primary Treatment: Supportive-expressive treatment
Phase: 3
Study Start date:
November 29, 2020
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
University of Haifa
Haifa,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.